JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Up 100.3% in July

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 520,831 shares, a growth of 100.3% from the June 30th total of 260,076 shares. Based on an average daily volume of 95 shares, the short-interest ratio is currently 5,482.4 days.

JCR Pharmaceuticals Price Performance

Shares of JCRRF stock remained flat at $3.31 during trading on Thursday. JCR Pharmaceuticals has a one year low of $3.15 and a one year high of $3.31. The company’s 50 day simple moving average is $3.35 and its 200 day simple moving average is $3.94.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.

In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.